ANIXA BIOSCIENCES, INC. Share-based Payment Arrangement, Expense
ANIXA BIOSCIENCES, INC. (ANIX) reported Share-based Payment Arrangement, Expense of -$1.11 million for the 3-month period ending 2020-04-30, per its 10-Q filed 2020-06-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2020-06-09
- ANIXA BIOSCIENCES, INC. share-based payment arrangement, expense for the quarter ending 2020-04-30 was -$1.11M.
- ANIXA BIOSCIENCES, INC. share-based payment arrangement, expense for the quarter ending 2020-01-31 was $1.02M, a 62.86% decline year-over-year.
- ANIXA BIOSCIENCES, INC. share-based payment arrangement, expense for the quarter ending 2019-10-31 was -$10.62M.
- ANIXA BIOSCIENCES, INC. share-based payment arrangement, expense for the quarter ending 2019-07-31 was $830.90K, a 82.05% decline year-over-year.
- ANIXA BIOSCIENCES, INC. share-based payment arrangement, expense for fiscal 2019 was -$5.71M.
- ANIXA BIOSCIENCES, INC. share-based payment arrangement, expense for fiscal 2018 was -$8.90M.
- ANIXA BIOSCIENCES, INC. share-based payment arrangement, expense for fiscal 2017 was -$1.68M.
- ANIXA BIOSCIENCES, INC. share-based payment arrangement, expense for fiscal 2015 was $2.68M, a 15.03% decline from fiscal 2014.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 9 month as first filed | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-04-30 | -$1.11M 10-Q · filed 2020-06-09 | -$2.13M 10-Q · filed 2020-06-09 | -$10.71M derived: sum of 3 quarters · filed 2020-06-09 | -$9.87M derived: sum of 4 quarters · filed 2020-06-09 | ||||
| 2020-01-31 | $1.02M 10-Q · filed 2020-03-09 | -$9.59M derived: sum of 2 quarters · filed 2020-03-09 | -$8.76M derived: sum of 3 quarters · filed 2020-03-09 | -$10.09M derived: sum of 4 quarters · filed 2020-06-09 | ||||
| 2019-10-31 | -$10.62M derived: 10-K 12 month − 10-Q 9 month · filed 2020-01-09 | -$9.79M derived: sum of 2 quarters · filed 2020-01-09 | -$11.11M derived: sum of 3 quarters · filed 2020-06-09 | -$5.71M 10-K · filed 2020-01-09 | ||||
| 2019-07-31 | $830.90K 10-Q · filed 2019-09-06 | -$490.55K derived: sum of 2 quarters · filed 2020-06-09 | $4.90M 10-Q · filed 2019-09-06 | -$11.86M derived: sum of 4 quarters · filed 2020-06-09 | ||||
| 2019-04-30 | -$1.32M 10-Q · filed 2020-06-09 | $1.32M 10-Q · filed 2019-06-12 | -$4.07M 10-Q · filed 2020-06-09 | $4.07M 10-Q · filed 2019-06-12 | -$12.69M derived: sum of 3 quarters · filed 2020-06-09 | -$8.07M derived: sum of 4 quarters · filed 2020-06-09 | ||
| 2019-01-31 | $2.75M 10-Q · filed 2020-03-09 | -$11.37M derived: sum of 2 quarters · filed 2020-03-09 | -$6.74M derived: sum of 3 quarters · filed 2020-03-09 | -$6.41M derived: sum of 4 quarters · filed 2020-03-09 | ||||
| 2018-10-31 | -$14.12M derived: 10-K 12 month − 10-Q 9 month · filed 2020-01-09 | -$9.49M derived: sum of 2 quarters · filed 2020-01-09 | -$9.16M derived: sum of 3 quarters · filed 2020-01-09 | -$8.90M 10-K · filed 2020-01-09 | ||||
| 2018-07-31 | $4.63M 10-Q · filed 2019-09-06 | $4.96M derived: sum of 2 quarters · filed 2019-09-06 | $5.23M 10-Q · filed 2019-09-06 | |||||
| 2018-04-30 | $331.71K 10-Q · filed 2019-06-12 | $598.68K 10-Q · filed 2019-06-12 | ||||||
| 2018-01-31 | $266.97K 10-Q · filed 2019-03-13 | |||||||
| 2017-10-31 | -$1.68M 10-K · filed 2019-01-11 | |||||||
| 2016-07-31 | $240.44K 10-Q · filed 2016-08-19 | $457.69K derived: sum of 2 quarters · filed 2016-08-19 | $570.19K 10-Q · filed 2016-08-19 | $908.20K derived: sum of 4 quarters · filed 2016-08-19 | ||||
| 2016-04-30 | $217.25K 10-Q · filed 2016-05-20 | $329.75K 10-Q · filed 2016-05-20 | $667.76K derived: sum of 3 quarters · filed 2016-05-20 | $1.45M derived: sum of 4 quarters · filed 2016-08-19 | ||||
| 2016-01-31 | $112.50K 10-Q · filed 2016-02-19 | $450.50K derived: sum of 2 quarters · filed 2016-02-19 | $1.23M derived: sum of 3 quarters · filed 2016-08-19 | $2.30M derived: sum of 4 quarters · filed 2016-08-19 | ||||
| 2015-10-31 | $338.01K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-23 | $1.12M derived: sum of 2 quarters · filed 2016-08-19 | $2.18M derived: sum of 3 quarters · filed 2016-08-19 | $2.68M 10-K · filed 2015-12-23 | ||||
| 2015-07-31 | $780.59K 10-Q · filed 2016-08-19 | $1.85M derived: sum of 2 quarters · filed 2016-08-19 | $2.34M 10-Q · filed 2016-08-19 | $3.14M derived: sum of 4 quarters · filed 2016-08-19 | ||||
| 2015-04-30 | $1.07M 10-Q · filed 2016-05-20 | $1.56M 10-Q · filed 2016-05-20 | $2.36M derived: sum of 3 quarters · filed 2016-05-20 | $2.83M derived: sum of 4 quarters · filed 2016-05-20 | ||||
| 2015-01-31 | $491.78K 10-Q · filed 2016-02-19 | $1.29M derived: sum of 2 quarters · filed 2016-02-19 | $1.76M derived: sum of 3 quarters · filed 2016-02-19 | $2.92M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-10-31 | $803.21K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-23 | $1.27M derived: sum of 2 quarters · filed 2015-12-23 | $2.43M derived: sum of 3 quarters · filed 2015-12-23 | $3.15M 10-K · filed 2015-12-23 | ||||
| 2014-07-31 | $469.48K 10-Q · filed 2015-08-18 | $1.63M derived: sum of 2 quarters · filed 2015-08-18 | $2.35M 10-Q · filed 2015-08-18 | $2.98M derived: sum of 4 quarters · filed 2015-08-18 | ||||
| 2014-04-30 | $1.16M 10-Q · filed 2015-05-22 | $1.88M 10-Q · filed 2015-05-22 | $2.51M derived: sum of 3 quarters · filed 2015-05-22 | $3.99M derived: sum of 4 quarters · filed 2015-05-22 | ||||
| 2014-01-31 | $720.64K 10-Q · filed 2015-03-09 | $1.36M derived: sum of 2 quarters · filed 2015-03-09 | $2.83M derived: sum of 3 quarters · filed 2015-03-09 | $3.70M derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2013-10-31 | $637.14K derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-01-29 | $2.11M derived: sum of 2 quarters · filed 2015-01-29 | $2.98M derived: sum of 3 quarters · filed 2015-01-29 | $3.80M 10-K · filed 2015-01-29 | $4.07M 10-K/A · filed 2014-01-17 | |||
| 2013-07-31 | $1.47M 10-Q/A · filed 2013-09-20 | $2.34M derived: sum of 2 quarters · filed 2013-09-20 | $3.16M 10-Q/A · filed 2013-09-20 | $3.43M derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2013-04-30 | $871.00K 10-Q/A · filed 2013-06-19 | $1.69M 10-Q/A · filed 2013-06-19 | $1.96M derived: sum of 3 quarters · filed 2014-03-17 | $2.55M derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2013-01-31 | $26.00K 10-Q · filed 2014-03-17 | $819.00K 10-Q/A · filed 2013-03-25 | $1.09M derived: sum of 2 quarters · filed 2014-03-17 | $1.68M derived: sum of 3 quarters · filed 2014-03-17 | $2.31M derived: sum of 4 quarters · filed 2014-03-17 | |||
| 2012-10-31 | $1.06M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2014-01-17 | $1.66M derived: sum of 2 quarters · filed 2014-01-17 | $2.29M derived: sum of 3 quarters · filed 2014-01-17 | $3.00M 10-K/A · filed 2014-01-17 | ||||
| 2012-07-31 | $595.00K 10-Q/A · filed 2013-09-20 | $0.00 10-Q · filed 2012-09-14 | $1.23M derived: sum of 2 quarters · filed 2013-09-20 | $1.94M 10-Q/A · filed 2013-09-20 | $111.00K 10-Q · filed 2012-09-14 | $4.96M derived: sum of 4 quarters · filed 2013-09-20 | ||
| 2012-04-30 | $631.00K 10-Q/A · filed 2013-06-19 | $1.34M 10-Q/A · filed 2013-06-19 | $4.36M derived: sum of 3 quarters · filed 2013-06-19 | $4.70M derived: sum of 4 quarters · filed 2013-06-19 | ||||
| 2012-01-31 | $713.00K 10-Q/A · filed 2013-03-25 | $3.73M derived: sum of 2 quarters · filed 2013-03-25 | $4.07M derived: sum of 3 quarters · filed 2013-03-25 | |||||
| 2011-10-31 | $3.02M derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-29 | $3.35M derived: sum of 2 quarters · filed 2013-01-29 | $3.66M 10-K · filed 2013-01-29 | |||||
| 2011-07-31 | $334.00K 10-Q · filed 2012-09-14 | $643.00K 10-Q · filed 2012-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |